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Recent clinical reports indicate that infection with dengue virus (DENV) commonly has ocular manifestations. The most serious
threat to vision is dengue retinopathy, including retinal vasculopathy and macular edema. Mechanisms of retinopathy are
unstudied, but observations in patients implicate retinal pigment epithelial cells and retinal endothelial cells. Human retinal cells
were inoculated with DENV-2 and monitored for up to 72 hours. Epithelial and endothelial cells supported DENV replication
and release, but epithelial cells alone demonstrated clear cytopathic effect, and infection was more productive in those cells.
Infection induced type I interferon responses from both cells, but this was stronger in epithelial cells. Endothelial cells increased
expression of adhesion molecules, with sustained overexpression of vascular adhesion molecule-1. Transcellular impedance
decreased for epithelial monolayers, but not endothelial monolayers, coinciding with cytopathic effect. This reduction was
accompanied by disorganization of intracellular filamentous-actin and decreased expression of junctional molecules, zonula
occludens 1, and catenin-β1. Changes in endothelial expression of adhesion molecules are consistent with the retinal
vasculopathy seen in patients infected with DENV; decreases in epithelial junctional protein expression, paralleling loss of
integrity of the epithelium, provide a molecular basis for DENV-associated macular edema. These molecular processes present
potential therapeutic targets for vision-threatening dengue retinopathy.
1. Introduction
Human infection with dengue virus (DENV) is transmitted
by Aedes species mosquitos and presents a broad spectrum
of disease, ranging from subclinical to “severe” dengue,
which is characterized by life-threatening plasma leakage,
hemorrhage, and/or organ failure [1, 2]. Recent research,
involving sophisticated statistical modeling of data derived
from over 8000 occurrence records, predicts that there are
approximately 390 million DENV infections worldwide each
year [3]. The Global Burden of Disease Study 2015 [4] has
highlighted DENV infection as an exception to the general
trend for falling mortality rates related to neglected tropical
diseases: between 2005 and 2015, the number of deaths from
DENV infection worldwide rose by almost 50% from 12,300
to 18,400.
Epidemics of virologically confirmed DENV infection are
on record from the 1940s [5], but there was little recognition
of dengue eye disease until the 2000s. Multiple forms of den-
gue eye disease have been reported recently, affecting the
orbit, ocular surface, and/or intraocular tissues [6]. Intraocu-
lar manifestations, particularly those that involve the retina,
are well described and are most likely to adversely impact
the vision. Dengue retinopathy may take the form of a retinal
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vasculopathy, with clinically apparent or presumed subclini-
cal retinal vasculitis, retinal hemorrhage, and/or vascular
occlusion [7–9]. This vasculopathy preferentially affects the
central macular region of the retina, but other macular
involvements are also observed. Macular edema is the most
prevalent form of maculopathy; another maculopathy, which
is termed “foveolitis,” is less common, but characteristic of
dengue retinopathy, and diagnosed on the basis of a yellow-
orange dot in the macula that has been localised to the border
of the neuroretina and retinal pigment epithelium by oph-
thalmic imaging [10–13]. Choroidal neovascularization at
the macula is also possible [14]. The prognosis of dengue ret-
inopathy is highly variable, ranging from full resolution to
permanent vision loss, irrespective of medical interventions
to reduce inflammation [6].
While cellular and molecular mechanisms of systemic
dengue have been extensively investigated, the basic processes
that contribute to dengue retinopathy remain unstudied. We
have initiated this investigation by studying interactions
between DENV and human retinal endothelial cells and reti-
nal pigment epithelial cells, using established cells lines and
primary cells, and laboratory and patient DENV isolates.
Our rationale for focusing on these cell subpopulations was
twofold. Firstly, retinal endothelial cells and retinal pigment
epithelial cells constitute the blood-retinal barrier [15], and
therefore they are the first cells DENV encounters when enter-
ing the retina. Secondly, clinical manifestations in patients
[8–14]—retinal vasculopathy and maculopathy—implicate
these cell subtypes in the ocular pathology. We present
observations relating to the susceptibility of the cells to
infection with DENV, the type I interferon (IFN) antiviral
and inflammatory responses of DENV-infected cells, and the
impact of DENV infection on barrier function of the cells.
2. Materials and Methods
2.1. Human Ocular Cell Lines. Primary human retinal cells
were isolated from cadaver donors obtained from the Eye
Bank of South Australia (Adelaide, Australia) within 24
hours of death with the approval of the Southern Adelaide
Clinical Human Research Ethics Committee.
To isolate primary human retinal pigment epithelial cells,
the method published by Blenkinsop et al. [16] was followed,
with some modifications. In brief, choroid with adherent
retinal pigment epithelium was dissected from posterior
eyecups and digested with 0.5mg/mL collagenase IA and
0.5mg/mL collagenase IV solution (Sigma-Aldrich, St. Louis,
MO). Retinal pigment epithelial cells were separated from
choroid as sheets in phosphate buffered saline (PBS) with
2% fetal bovine serum (FBS, Bovogen Biologicals, Keilor
East, Australia, or GE Healthcare-HyClone, Logan, UT)
and layered over 20% sucrose in medium. Cells were
cultured in Dulbecco’s modified Eagle’s medium : nutrient
mixture F12 (DMEM :F12, Thermo Fisher Scientific-Gibco,
Grand Island, NY) and minimum essential medium Eagle
(MEM, Sigma-Aldrich), in a ratio of 1 : 1, supplemented with
FBS (initially at 10%, reduced to 2% after 2 days), 1x N1
Medium Supplement, 0.25mg/mL taurine, 0.02mg/mL
hydrocortisone, and 0.013 ng/mL triiodothyronine (all from
Sigma-Aldrich), and 1x MEM Non-Essential Amino
Acids Solution, 1x GlutaMAX Supplement, and 100U/mL
penicillin-100μg/mL streptomycin (all from Thermo Fisher
Scientific-Gibco) at 37°C and 5% CO2 in air.
To isolate primary human retinal endothelial cells, we
followed the method we have previously published [17]. Ret-
ina was dissected from posterior eyecups, and digested with
0.25 to 1mg/mL type II collagenase (Thermo Fisher Scien-
tific-Gibco). After 7 days of culture in MCDB-131 medium
(Sigma-Aldrich) with 2% FBS and endothelial growth factors
(EGM-2 SingleQuots supplement, omitting FBS, hydrocorti-
sone and gentamicin; Clonetics-Lonza, Walkersville, MD),
endothelial cells were purified using Dynal magnetic beads
(Thermo Fisher Scientific-Invitrogen, Oslo, Norway) coated
with mouse monoclonal anti-human CD31 antibody (BD Bio-
sciences-Pharmingen, San Diego, CA), and grown in modified
MCDB-131mediumwith 10% FBS at 37°C and 5%CO2 in air.
The ARPE-19 human retinal pigment epithelial cell line
(American Type Culture Collection (ATCC), Manassas, VA)
[18] was cultured in DMEM:F12 supplemented with 5%
FBS at 37°C and 5% CO2 in air. The human retinal endothelial
cell line was generated and characterized in-house, as we have
reported in detail [17]. In brief, endothelial cells, isolated as
described above, were expanded by transduction with the
mouse recombinant amphotropic retrovirus, LXSN16E6E7
(gifted by Denise A. Galloway, PhD, Fred Hutchinson Cancer
Institute Seattle, WA) [19]. This cell line retains an endothelial
phenotype, including expression of endothelial markers and
formation of capillary-like tubes on basement membrane
substitute [17]. Retinal endothelial cells were cultured in
MCDB-131 medium supplemented with 5% FBS and endo-
thelial growth factors at 37°C and 5% CO2 in air.
2.2. Dengue Virus. The DENV strains includedMon601 (full-
length, infectious recombinant clone of DENV serotype 2
(DENV-2) New Guinea C strain, originally cloned from a
mouse brain-adapted isolate) [20] and PUO-312 (DENV-2
strain isolated in the field during the 1980 Thai dengue
epidemic, and provided by Peter J. Wright, PhD (Monash
University, Melbourne, Australia) [21, 22]. Both Mon601
and PUO-312 strains have tropism for human cell lines and
primary cells [23–25]. The Mon601 strain virus was gener-
ated by transfection of in vitro transcribed DENV RNA into
baby hamster kidney BKH-21 fibroblasts and amplified in
C6/36 mosquito cells. The PUO-312 strain virus was contin-
uously propagated in C6/36 mosquito cells. Virus stocks were
titrated by plaque assay on Vero cells (ATCC), with plaques
detected by neutral red overlay, and expressed as plaque-
forming units (pfu)/mL.
2.3. Viral Infection of Human Ocular Cells. Unless otherwise
stated, retinal cells were plated for confluence on surfaces
appropriate to the assay in modified DMEM :F12 or
modified MCDB-131 medium, respectively, and incubated
overnight at 37°C and 5% CO2 in air. Cell monolayers were
inoculated with DENV at multiplicity of infection of 1, or
mock-infected, in FBS-free medium for 90 minutes with
intermittent rocking, washed 3 times with fresh FBS-free
medium, and returned to modified DMEM :F12 or modified
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MCDB-131 medium for incubations of up to 72 hours
postinoculation. Viral titer in culture supernatant was
determined by plaque assay, as described above.
2.4. Immunocytochemistry. Confluent monolayers of ARPE-
19 retinal pigment epithelial cells or retinal endothelial cells
on gelatin-coated glass coverslips, infected with DENV-2 or
mock-infected, were fixed in 4% paraformaldehyde, rinsed
in 70% ethanol, and stored in sterile PBS. Monolayers were
permeabilized with 0.05% IGEPAL CA-630 (Sigma-Aldrich)
and blocked in 4% goat serum (Thermo Fisher Scientific-
Gibco), 5% FBS, and 0.4% bovine serum albumin
(Sigma-Aldrich) in PBS. Cells were labeled with mouse
anti-double-stranded RNA (dsRNA) monoclonal antibody
(SCICSONS, Budapest, Hungary: described, J2) diluted to
2.5μg/mL, or serum from a DENV-infected human (gift
of Dr. Wright) diluted 1 in 3000, both in PBS with 2%
goat serum, for 60 minutes at room temperature, and sub-
sequently washed in PBS. Cells were incubated with Alexa
Fluor 488-tagged goat anti-mouse IgG or Alexa Fluor 555-
goat anti-human IgG (Thermo Fisher Scientific-Molecular
Probes, Eugene, OR) at 2μg/mL in PBS with 2% goat
serum for 30 minutes at room temperature. After washing
with PBS, cells were counterstained with Hoechst 33342
nucleic acid stain (Thermo Fisher Scientific-Molecular
Probes) for 10 minutes. Monolayers were mounted in Pro-
Long Gold Antifade Mountant (Thermo Fisher Scientific-
Molecular Probes) and imaged by confocal microscopy
(Leica TCS SP5 Confocal Microscope: Leica Microsystems,
Mannheim, Germany).
2.5. RNA Isolation, Reverse Transcription, and Polymerase
Chain Reaction. At the conclusion of infections, total RNA
was extracted from TRIzol Reagent (Gibco)-lysed cells,
according to the manufacturer’s instructions, and stored at
−80°C ahead of the reverse transcription (RT). RNA concen-
tration was determined by spectrophotometry on the
NanoDrop 2000 instrument (Thermo Fisher Scientific,
Wilmington, DE). For examination of the host cell response
to infection, reverse transcription was performed using the
iScript Reverse Transcription Supermix for RT-qPCR (Bio-
Rad, Hercules, CA), with 500ng of RNA template yielding
20μL cDNA. Quantitative real-time PCR was performed
on the CFX Connect Real-Time PCR Detection System
(Bio-Rad) using the following: 2μL of cDNA, diluted 1 in
10; 4μL of iQ SYBR Green Supermix; 1.5μL each of
20μM forward and reverse primers; and 11μL of nuclease-
free water for each reaction. Amplification consisted of the
following: a precycling hold at 95°C for 5 minutes; 40 cycles
of denaturation for 30 seconds at 95°C; annealing for 30 sec-
onds at 60°C; extension for 30 seconds at 72°C; and a postex-
tension hold at 75°C for 1 second. A melting curve,
representing a 1-second hold at every 0.5°C between 70°C
and 95°C, was generated to confirm that a single peak was
produced for each primer set. Standard curves, produced
with serially diluted product, confirmed PCR efficiency of
85% or greater. Size of PCR product was confirmed by elec-
trophoresis on 2% agarose gel. The cycle threshold was
measured, with Cq determination mode set to regression.
Relative expression was determined using the method
described by Pfaffl [26], normalized to two stable reference
genes—glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and TATA-binding protein (TBP). For quantification of intra-
cellular DENV copy number, a similar methodology was used.
Reverse transcription was performed using M-MuLV reverse
transcriptase with random hexamers (New England BioLabs,
Ipswich, MA). Quantitative real-time PCR was performed
on a Rotor-Gene 6000 (Corbett Life Science, Melbourne,
Australia). The DENV RNA copy number was calculated
from a standard curve of Mon601 strain DENV-2 that was
generated in a parallel PCR and normalized against pepti-
dylprolyl isomerase A (PPIA). Primer sequences for all tran-
scripts are presented in Table 1.
2.6. Secreted Interferon-Beta Immunoassay. Culture super-
natants from DENV- or mock-infected ARPE-19 cells
retinal pigment epithelial cells and retinal endothelial cells
were assayed for human IFN-β with an AlphaLISA
(PerkinElmer, Waltham, MA), with a limit of detection
of 1 ng/mL. Human IFN-β standard solutions were prepared
in medium matched to cell population. The AlphaLISA was
performed following the manufacturer’s “Quick” protocol
exactly, with 2μL standard or culture supernatant used in
each 20μL assay. Protein concentration was calculated
from the AlphaLISA signal read on an EnSight plate
reader (PerkinElmer).
2.7. Retinal Endothelial VCAM-1 Immunoassay. The cellular
adhesion molecule ELISA was adapted from a protocol pub-
lished by Hartwig et al. [27], as we have previously described
[28]. At 48 hours after inoculation with DENV, confluent
monolayers of retinal endothelial cells in wells of 96-well
plates, infected with DENV-2 or mock infected, were washed
twice in PBS with 0.1% Tween-20 (PBS/Tween-20), fixed in
1% paraformaldehyde for 30 minutes, and washed in PBS/
Tween-20. Following a 30-minute block with 5% w/v skim
milk in PBS (blocking solution), the monolayers were
incubated with mouse monoclonal anti-human vascular
cell adhesion molecule 1 (VCAM-1) antibody (BD Phar-
mingen: catalogue number 555645) or mouse monoclonal
IgG (BD Pharmingen) at 1μg/mL in blocking solution
for 45 minutes at room temperature (n = 8 monolayers/
condition) and washed 5 times with PBS/Tween-20. Subse-
quently, monolayers were incubated with Alexa Fluor 488-
conjugated secondary goat anti-human immunoglobulin
antibody at 2.5μg/mL in blocking solution for 30 minutes
at room temperature and washed 5 times with PBS/Tween-
20. Finally, monolayers were treated with 300 nM DAPI
(Sigma-Aldrich) in PBS for 5 minutes and washed 3 times
in PBS. All treatments after the fixation step were performed
on a slowly rotating orbital shaker. Monolayer fluorescence
was determined on the VICTOR X3 Multilabel Plate Reader
(Perkin Elmer) using 485 excitation and 535 emission (Alexa
Fluor 488) filters and 355 excitation and 460 emission (DAPI)
filters. Mean background fluorescence was determined
from mouse IgG-incubated wells for each condition, and
this value was subtracted from wells incubated with anti-
human VCAM-1 antibody, for the matching condition.
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Alexa Fluor 488 readings were adjusted for DAPI readings
from the same wells to account for differences in cell numbers
between wells.
2.8. Monolayer Permeability Assay. ARPE-19 retinal pigment
epithelial cells or retinal endothelial cells were seeded at
20,000 cells per well in xCELLigence E-Plate 16 (well diame-
ter = 5mm) (ACEA Biosciences, San Diego, CA) in modified
DMEM :F12 or MCDB-131 medium, respectively. After a
2-hour period of recovery, plates were incubated overnight in
an xCELLigence RTCA instrument (ACEA Biosciences, San
Diego, CA), which maintained the cell monolayers at 37°C
and 5% CO2 in air, while reading electrical impedance across
the monolayers every hour. Plates were temporarily removed
from the instrument for addition of DENV in FBS-free
medium at MOI of 1, and again temporarily removed from
the instrument 90 minutes later, for removal of the DENV
suspension and replacement with fresh FBS-supplemented
Table 1: Primer pairs and product sizes for gene transcripts.




















































∗References for primers sequences sourced from the literature are provided. For primer pairs designed in-house, products were confirmed by sequencing. B2M:
β-2-microglobulin; CLDN5: claudin 5; CTNNB1: catenin-β1; DENV: dengue viral RNA; EIF2AK2: eukaryotic translation initiation factor 2-alpha kinase 2;
GAPDH: glyceraldehyde-3-phosphate dehydrogenase; IFITM1: interferon-induced transmembrane protein 1; IFN-β: interferon-β; IL-6: interleukin-6;
ISG15: interferon-stimulated gene 15; JAM-3: junctional adhesion molecule 3; OCLN: occludin; PPIA: peptidylprolyl isomerase A; RSAD2: radical SAM
domain-containing 2 (viperin); TBP: TATA-binding protein; TNF-α: tumor necrosis factor-α; ZO-1: zonula occludens 1.
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medium. Subsequently, the plates were incubated for approx-
imately 60 hours.
2.9. Intracellular Actin Labeling. Confluent monolayers of
ARPE-19 retinal pigment epithelial cells or retinal endothe-
lial cells on gelatin-coated glass coverslips were fixed and
stored, and immediately prior to labeling, washed and
permeabilized, as described above for immunocytochemis-
try. Cells were labeled with TRITC-tagged phalloidin (Sigma)
at 1μg/mL in PBS with 2% goat serum for 30 minutes at
room temperature. Cells were washed in PBS and counter-
stained with Hoechst 33342 nucleic acid stain for 10 minutes.
Monolayers were mounted in ProLong Gold Antifade Moun-
tant and imaged by confocal microscopy.
2.10. Statistical Analysis. Data generated under DENV- and
mock-infected conditions were compared by unpaired or
paired Student’s t-tests, using CFX Manager version 3.1
(Bio-Rad) or GraphPad Prism v6.04 (GraphPad Software,
La Jolla, CA). In all analyses, a significant difference was
defined as one yielding a p value less than 0.05.
3. Results
3.1. Human Retinal Pigment Epithelial Cells and Human
Retinal Endothelial Cells Are Permissive to DENV Infection.
To initiate the investigation of interactions between DENV,
and human retinal pigment epithelial cells and human retinal
endothelial cells, we first evaluated the susceptibility of these
cells to infection with the virus. We followed the course of
DENV-2 infection in ARPE-19 retinal pigment epithelial
cells (Figure 1) and in retinal endothelial cells (Figure 2) up
to 72 hours by standard cellular and molecular methods.
Within 24 hours of inoculation with the virus, both human
retinal cell populations demonstrated increased transcription
of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6)
(Figures 1(a) and 2(a)), which are key cytokines in the devel-
opment of intraocular inflammation. For pigment epithelial
cells, cytopathic effect of the infection was clearly apparent
by 48 hours (Figure 1(b)). Immunocytochemistry identified
dsRNA and DENV-Ag in a majority of pigment epithelial
cells (Figure 1(c)), and RT-qPCR detected a high copy num-
ber of DENV-2 RNA in these cells (Figure 1(d)). In contrast,
for endothelial cells, there was no obvious cytopathic effect
(Figure 2(b)); relatively few cells were positively labeled for
dsRNA and DENV-Ag (Figure 2(c)); and RT-qPCR detected
a substantially lower copy number of DENV-2 RNA
(Figure 2(d)). Analysis of culture supernatant by plaque assay
indicated release of infectious virus from both cell types,
although viral titer was higher in supernatant harvested from
pigment epithelial monolayers than that from endothelial
monolayers (Figures 1(d) and 2(d), resp.). We also veri-
fied susceptibility of cell populations to infection with
DENV-2 by inoculating primary retinal pigment epithelial
cells and primary retinal endothelial cells isolated from
human cadaver donor eyes. Immunocytochemistry identified
dsRNA and DENV-Ag in a majority of primary retinal pig-
ment epithelial cells, but relatively few primary retinal endo-
thelial cells after 48 hours (Figure 3). Taken together, these
data suggest both human retinal pigment epithelial cells
and human retinal endothelial cells support DENV infection,
although the course of the infection may differ between the
cell populations.
3.2. DENV Infection Induces a Stronger Type I Interferon
Response by Human Retinal Pigment Epithelial Cells Than
Human Retinal Endothelial Cells. The type I IFN response
is the primary antiviral mechanism effected by human cells
[29]. To investigate this response in human retinal pigment
epithelial cells and human retinal endothelial cells, we mea-
sured IFN-β protein in culture supernatant collected from
DENV-2-infected and mock-infected cells at 24, 48, and 72
hours postinoculation, using an immunoassay, and we
studied induction of transcripts encoding selected IFN-
stimulated genes (ISGs) by RT-qPCR at the same time points
(Figure 4). Mock-infected cells produced no IFN-β protein,
to a detection limit of 1 ng/mL. Following infection, however,
ARPE-19 retinal pigment epithelial cells secreted IFN-β in
concentrations exceeding 10ng/mL at all time points
(Figure 4(a)). Infected retinal endothelial cells also secreted
IFN-β, but the cytokine was not detectable until 48 hours,
and concentration was substantially lower, close to the detec-
tion limit of the assay (Figure 4(b)). Both cell populations
upregulated ISGs in response to viral infection, including fac-
tors that inhibit viral entry into the host cell (IFN-induced
transmembrane protein 1 (IFITM1)), intracellular replica-
tion of virus (eukaryotic translation initiation factor 2-alpha
kinase 2 (EIF2AK2) and radical SAM domain-containing 2
(RSAD2), also known as viperin), and viral egress from the
cell (IFN-stimulated gene 15 (ISG15)) (Figures 4(c) and
4(d), resp.). These results indicate that human retinal pig-
ment epithelial cells and human retinal endothelial cells both
mount an antiviral type I IFN response, but they suggest that
this response is more vigorous in the epithelial cells.
3.3. DENV Infection Impacts Expression of Cell Adhesion
Molecules by Human Retinal Endothelium. Retinal vasculop-
athy characterized by retinal vasculitis—inflammation of the
retinal blood vessels—is a common manifestation of dengue
retinopathy [6]. Human retinal endothelial cells express high
levels of adhesion molecules, and expression is further
induced under conditions of inflammation, which promotes
leukocyte migration into the retina [17]. We examined tran-
script levels of highly expressed retinal endothelial cell
adhesion molecules at 24, 48, and 72 hours postinoculation
with DENV-2: E-selectin, intercellular adhesion molecule 1
(ICAM-1), VCAM-1, activated leukocyte cell adhesion mol-
ecule (ALCAM), and CD44 (Figure 5(a)). Viral infection
led to significant increase in endothelial transcript expression
of all adhesion molecules, with the exception of E-selectin, at
one or more tested time intervals. Fold increase was highest
for VCAM-1 transcript, and this was sustained across 72
hours, suggesting a key role for VCAM-1 in particular, in
leukocyte trafficking to the retina in dengue retinopathy.
Therefore, we confirmed expression of VCAM-1 with an
immunoassay that detected cell membrane-bound adhesion
molecule on retinal endothelial monolayers at 48 hours
postinoculation: VCAM-1 was significantly increased on
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Figure 1: Infection of human retinal pigment epithelial cells with DENV: viral strain =Mon601; multiplicity of infection = 1; evaluated time
points postinoculation = 6, 24, 48, and 72 hours (hr). (a) Graphs showing expression of tumor necrosis factor-α (TNF-α) and interleukin-6
(IL-6) transcripts in DENV-infected retinal pigment epithelial cells versus mock-infected cells. Reference genes were glyceraldehyde-3-
phosphate dehydrogenase and TATA-binding protein. Bars represent mean relative expression, with error bars showing standard
deviation. n = 3 cultures/condition. Data were analyzed by two-tailed Student’s t-test. (b) DENV-infected and mock-infected retinal
pigment epithelial cells viewed by light microscopy. Original magnification = 100x. (c) DENV- and mock-infected retinal pigment
epithelial cells immunolabeled to detect double-stranded RNA (dsRNA) and DENV antigen (Ag). Alexa Fluor 555 (red) and Alexa Fluor
488 (green) with Hoechst 33342 nuclear counterstain (blue). Original magnification: 630x. (d) Graphs of DENV RNA copy number for
DENV-infected retinal pigment epithelial monolayers and plaque-forming units (pfu) for culture supernatant collected from infected cells.
n = 3 cultures/condition. Bars represent mean DENV RNA copy number (relative to peptidylprolyl isomerase A (PPIA)) or pfu/mL, with
error bars showing standard deviation.































































































































Figure 2: Infection of human retinal endothelial cells with DENV: viral strain =Mon601; multiplicity of infection = 1; evaluated time points
postinoculation = 6, 24, 48, and 72 hours (hr). (a) Graphs showing relative expression of tumor necrosis factor-α (TNF-α) and interleukin-6
(IL-6) transcripts in DENV-infected endothelial cells versus mock-infected cells. Reference genes were glyceraldehyde-3-phosphate
dehydrogenase and TATA-binding protein. Bars represent mean relative expression, with error bars showing standard deviation. n = 3
cultures/condition. Data were analyzed by two-tailed Student’s t-test. (b) DENV-infected and mock-infected endothelial cells viewed by
light microscopy. Original magnification = 100x. (c) DENV- and mock-infected endothelial cells immunolabeled to detect double-stranded
RNA (dsRNA) and DENV antigen (Ag). Alexa Fluor 555 (red) and Alexa Fluor 488 (green) and with Hoechst 33342 nuclear counterstain
(blue). Original magnification: 630x. (d) Graphs of copy number of DENV RNA for DENV-infected endothelial monolayers and plaque-
forming units (pfu) for culture supernatant collected from infected cells. n = 3 cultures/condition. Bars represent DENV RNA copy
number (relative to cellular peptidylprolyl isomerase A (PPIA)) or mean pfu/mL, with error bars showing standard deviation.
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DENV-2-infected retinal endothelial cells, in comparison to
mock-infected cells (Figure 5(b)).
3.4. DENV Infection Promotes Permeability of Human
Retinal Pigment Epithelial Monolayers, but Not Human
Retinal Endothelial Monolayers, Accompanied by Decreased
Expression of Junctional Molecules. Since excessive accumula-
tion of extracellular fluid in the macular region disturbs neu-
roretinal anatomy, macular edema carries the greatest risk to
the vision in dengue retinopathy [6]. The blood-retinal bar-
rier is formed by the retinal pigment epithelium, which abuts
the highly fenestrated choroidal vasculature and the retinal
vascular endothelium [30]. We evaluated the impact of
DENV-2 infection on barrier function and phenotype of
these cells (Figure 6). Effect on barrier function was assessed
in real time by measuring transcellular electrical resistance
every hour over a period of 3 days. Although electrical resis-
tance across ARPE-19 retinal pigment epithelial monolayers
infected with DENV-2 was higher than across mock-infected
cells, at approximately 36 hours postinoculation, electrical
resistance began to decline across the infected monolayers,
while it continued to climb across mock-infected cells
(Figure 6(a)). To independently confirm this alteration, we
examined the filamentous- (F-) actin arrangement by phal-
loidin staining cells at 24 and 48 hours postinoculation. In
mock-infected cells, a well-organized intracellular network
of filaments was maintained, whereas in DENV-2-infected
cells, disorganization of the network, with aggregations and
loss of filaments colocalizing with areas of viral replication,
was observed by 24 hours (Figure 6(b)). To determine the
molecular basis for loss of barrier function, we examined
the expression of transcripts encoding molecules involved
in epithelial adherens and tight junctions at 24, 48, and 72
hours postinoculation by RT-qPCR: expression of zonula
occludens 1 (ZO-1), junctional adhesion molecule 3 (JAM-3),
and/or catenin-β1 (CTNNB1) was decreased across these
intervals (Figure 6(c)). In contrast to changes in electrical resis-
tance observed in DENV-2-infected retinal pigment epithelial
monolayers, electrical resistance measured across retinal endo-
thelial monolayers was comparable between DENV-2-infected
and mock-infected cells, rising over approximately 48 hours
before stabilizing (Figure 6(d)). Consistently, the expression
of transcripts encoding molecules involved in endothelial
adherens and tight junctions, including endothelial-specific
VE-cadherin, were not impacted by infection (Figure 6(e)).
Taken together, these data suggest breakdown of the blood-
retinal barrier during dengue retinopathy occurs at the level
of the retinal pigment epithelium.
3.5. Response of Human Retinal Cells to DENV Infection Is
Replicated with Natural Isolate Strain. Our studies were per-
formed with the laboratory-cloned Mon601 DENV-2 strain.
To confirm the relevance of our findings to the human infec-
tious disease, we repeated selected infectivity and host cell
response experiments using PUO-312, which is a DENV-2
strain isolated from an infected human [21, 22] (Figure S1
available online at https://doi.org/10.1155/2017/3164375).
Experiments were analyzed at 48 hours postinoculation with
PUO-312, which was the time at which we observed most
marked pathological changes in experiments with Mon601.
Immunocytochemistry identified dsRNA and DENV-Ag in
PUO-312-infected ARPE-19 retinal pigment epithelial cells
and retinal endothelial cells, but not mock-infected cells
(Figure S1 A and B, resp.). Infection with PUO-312 resulted
in similar changes in transcript expression to those observed
with the laboratory clone: increased TNF-α in retinal pig-
ment epithelial cells and retinal endothelial cells (not statisti-
cally significant for endothelial cells); increased IFN-β in
retinal pigment epithelial cells and retinal endothelial cells;
increased VCAM-1 in retinal endothelial cells; and decreased
CTNNB1 in retinal pigment epithelial cells, but not retinal
endothelial cells (Figure S1 C and D, resp.). These results
provide evidence that observations made in experiments
using the Mon601 are representative of cellular and
molecular responses to DENV strains responsible for dis-
ease in humans.


















Figure 3: Infection of primary human retinal pigment epithelial cells and primary human retinal endothelial cells with DENV: viral
strain =Mon601; multiplicity of infection = 1; evaluated time point postinoculation = 48 hours. (a) DENV- and mock-infected retinal
pigment epithelial cells and (b) DENV- and mock-infected retinal endothelial cells immunolabeled to detect double-stranded RNA
(dsRNA) and DENV antigen (Ag). Alexa Fluor 555 (red) and Alexa Fluor 488 (green) with Hoechst 33342 nuclear counterstain (blue).
Original magnification: 630x.
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Figure 4: Antiviral type I interferon (IFN) response of human retinal pigment epithelial cells and human retinal endothelial cells infected
with DENV: viral strain =Mon601; multiplicity of infection = 1; evaluated time points postinoculation = 24, 48, and 72 hours (hr). (a) and
(b) Graphs showing IFN-β protein concentration in culture supernatant of (a) DENV-infected retinal pigment epithelial cells and (b)
DENV-infected endothelial cells. Bars represent mean protein concentration, with error bars showing standard deviation. n = 3 cultures/
condition. No IFN-β protein was detected in mock-infected cells. ND=not detectable. (c) and (d) Graphs showing relative transcript
expression for IFN-stimulated gene products in (c) DENV-infected versus mock-infected retinal pigment epithelial cells and (d) DENV-
infected versus mock-infected endothelial cells. Reference genes were glyceraldehyde-3-phosphate dehydrogenase and TATA-binding
protein. Bars represent mean relative expression, with error bars showing standard deviation. n = 3 cultures/condition. Data were analyzed
by two-tailed Student’s t-test. IFITM1= IFN-induced transmembrane protein 1; EIF2AK2= eukaryotic translation initiation factor 2-alpha
kinase 2; RSAD2= radical SAM domain-containing 2 (also known as viperin); ISG15 = IFN-stimulated gene 15.
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Figure 5: Cell adhesion molecule expression by human retinal endothelial cells infected with DENV: viral strain =Mon601; multiplicity of
infection = 1; evaluated time points postinoculation = 24, 48, and 72 hours (hr). (a) Graphs showing relative transcript expression for
adhesion molecules in DENV-infected versus mock-infected endothelial cells. Reference genes were glyceraldehyde-3-phosphate
dehydrogenase and TATA-binding protein. Bars represent mean relative expression, with error bars showing standard deviation. n = 3
cultures/condition. Data were analyzed by two-tailed Student’s t-test. (b) Graph showing relative expression of VCAM-1 protein on the
surface of DENV-infected versus mock-infected endothelial cells. Each pair of circles joined by a line represents the mean expression for
DENV-infected versus mock-infected endothelial cells for one of 3 independent experiments. n = 8 cultures/condition. Data were analyzed
by one-tailed paired Student’s t-test. ICAM-1 = intercellular adhesion molecule, 1; VCAM-1 = vascular cell adhesion molecule 1;
ALCAM= activated leukocyte cell adhesion molecule.
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Dengue retinopathy is the most serious ocular involvement
that follows systemic infection with DENV [6]. Data col-
lected during the 2005 Singapore epidemic [12] indicate that
this condition may affect as many as 10% of patients who
require hospitalization for DENV infection. There is no anti-
viral drug that specifically targets DENV, and in the absence
of studies of disease pathogenesis, treatment of dengue reti-
nopathy is limited to reducing the host inflammatory
response nonspecifically by treatment with locally or system-
ically delivered corticosteroid and/or intravenous immuno-
globulin [10, 11]. We have conducted a series of experiments
designed to investigate basic mechanisms operating during
DENV retinopathy, based on multiple clinical observations
that implicate cells of the blood-retinal barrier, retinal pig-
ment epithelial cells and retinal endothelial cells, in the ocular
pathology [7–13].
Infectivity studies, including immunolabeling of viral
dsRNA and DENV antigen in cultured cells, RT-qPCR of
DENV transcript in cells, and plaque assay of cell culture
supernatant, all indicated that retinal pigment epithelial cells
and retinal endothelial cells were permissive to viral infection
and supported release of infectious virus. Infection of human
retinal cells with DENV has not been studied previously, but
these retinal cell populations are reported to be susceptible
to infection with other RNA and DNA viruses [31–35].
Work performed by ourselves and independent researchers
[23, 36, 37] has highlighted that nonocular endothelial cell
populations, including endothelial cells from the human
umbilical vein and the human dermal microvasculature, are
susceptible to infection with DENV, but with a relatively low
proportion of cells infected; this has been attributed to both
extracellular conditions and cellular phenotype, including
the expression of cell surface receptors for the virus. Consis-
tently, we observed that human retinal pigment epithelial cells
showed evidence of the viral cytopathic effect and were
infected in larger numbers, contained higher viral copy
number, and released virus at higher titer than human retinal
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Figure 6: Effect of DENV infection on barrier function of human retinal pigment epithelial cells and human retinal endothelial cells: viral
strain =Mon601; multiplicity of infection= 1; evaluated up to 60 hours (hr) postinoculation. (a) and (d) Plots of electrical resistance across
(a) DENV-infected retinal pigment epithelial monolayers and (d) DENV-infected endothelial monolayers versus mock-infected monolayers,
measured at hourly intervals and expressed as transcellular resistance by xCELLigence. Lines indicate mean electrical resistance: blue lines
represent DENV-infected monolayers and red lines represent mock-infected monolayers. Error bars indicate standard error of mean. n = 4
monolayers/condition. Arrowheads mark time of inoculation and 24 and 48 hours postinoculation. Drop in resistance immediately after
inoculation with virus is due to removal of plate from xCELLigence for inoculation procedure. (b) DENV- and mock-infected retinal
pigment epithelial cells immunolabeled to detect double-stranded RNA (dsRNA) and filamentous- (F-) actin. Alexa Fluor 555 (red) and
Alexa Fluor 488 (green) with Hoechst 33342 nuclear counterstain (blue). Images are merged z-stacks. Original magnification: 630x. (c) and
(e) Graphs showing relative transcript expression for junctional molecules in (c) DENV-infected retinal pigment epithelial cells and (e)
DENV-infected endothelial cells versus mock-infected cells. Reference genes were glyceraldehyde-3-phosphate dehydrogenase and TATA-
binding protein. Bars represent mean relative expression, with error bars showing standard deviation. n = 3 cultures/condition. Data were
analyzed by two-tailed Student’s t-test. ZO-1= zonula occludens 1; CLDN5= claudin 5; OCLN=occludin; JAM-3= junctional adhesion
molecule 3; CTNNB1= catenin-β1. CLDN5 and VE-cadherin were not detected in epithelial cells.
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infection with higher production of IFN-β, although both
pigment epithelial cells and endothelial cells types effected
a type-1 IFN response.
The human retina may manifest pathology after systemic
infection with a diverse spectrum of RNA and DNA viruses
[38]. Clinical features of viral retinopathy vary with the path-
ogen, whichmay reflect factors such as route of viral entry into
the eye, specific retinal cell tropism of the virus, retinal host
cell response to the virus, and the host immune response to
the infection. In addition to DENV, two other flaviviruses—
West Nile virus and Zika virus—may cause retinopathy, with
characteristic forms that differ from that of dengue retinop-
athy. West Nile virus infection typically causes multifocal
chorioretinal lesions that occur in linear streaks following
the course of retinal nerve fibers [39, 40]. Zika virus retinop-
athy is described mostly in infants born with microcephaly,
who were infected in utero; affected infants suffer pigment
mottling of the retina and large areas of chorioretinal
atrophy that often are located at the macula and shaped like
a torpedo [41, 42]. Recently, other groups have described
responses of several retinal cell populations to infection
with West Nile virus or Zika virus [31, 33, 43]. Our
work is directed at understanding dengue retinopathy in
particular—retinal vasculopathy and maculopathy—at the
cellular and molecular level.
Retinal vasculitis is a prominent clinical feature of dengue
retinopathy and may be associated with retinal hemorrhages
and/or vascular occlusions [6]. At the molecular level, cell
adhesion molecules on activated retinal vascular endothe-
lium mediate interactions with myeloid and lymphoid leuko-
cyte subsets that permit leukocyte transendothelial migration
[17]. Studies of noninfectious retinal inflammation, utilizing
mouse experimental autoimmune uveoretinitis or human
simulations, have implicated integrins, superfamily immuno-
globulin members, and/or CD44 in leukocyte trafficking into
the retina [44–47]. We measured increased expression of
ICAM-1, VCAM-1, ALCAM, and CD44 transcript by
infected human retinal endothelial cells at different intervals
after DENV infection. Increased expression of VCAM-1 was
sustained across all intervals that we studied, and this was
confirmed by detection of increased VCAM-1 protein on
the surface of DENV-infected cells. A key role for VCAM-1
in the pathogenesis of dengue retinopathy is corroborated
by several recent studies of systemic biomarkers in persons
infected with DENV. Yacoub et al. [48] linked plasma levels
of cleaved VCAM-1, but not E-selectin or ICAM-1, with
parameters of microcirculatory dysfunction in patients
with serologically confirmed dengue of any DENV sero-
type. Liao et al. [49] reported soluble VCAM-1 to be an
early biomarker of severe dengue versus dengue fever in
adults infected with DENV-1, and Mangione et al. [50]
similarly associated soluble VCAM-1 with pediatric den-
gue shock syndrome, in comparison to dengue fever and
dengue hemorrhagic fever.
Maculopathy is the other common manifestation of den-
gue retinopathy, usually presenting as macular edema and
implying breakdown of the blood-retinal barrier. Velandia-
Romero et al. [51] demonstrated the ability of DENV to
bridge the vascular-tissue barrier in a mouse in vitro model,
in which transwells were populated with mouse brain endo-
thelial cells, and transendothelial potential was measured
four times daily for 2 days: movement of virus was accompa-
nied by an increased permeability of the monolayer that was
partially abrogated by co-culture of the endothelial cells with
mouse astrocytes. The blood-retinal barrier is constituted at
two anatomically separate locations, by the nonfenestrated
retinal vascular endothelium and the retinal pigment epithe-
lium [30]. We observed increasing permeability of infected
retinal pigment epithelial monolayers, in comparison to
retinal endothelial monolayers, using a closed system with
hourly electrical impedance readings over 3 days. This
response of the retinal pigment epithelium was accompanied
by loss of cellular F-actin structure and a reduced expression
of junctional molecules that was not recorded for human ret-
inal endothelial cells. This suggests macular edema may
reflect primarily the infection of retinal pigment epithelium.
Involvement of the retinal pigment epithelium is also consis-
tent with the less common, but highly characteristic, clinical
finding of foveolitis, which occurs at the junction of photore-
ceptors and epithelium. Interestingly, in a model of retinal
infection with a parasite, Toxoplasma gondii, which used
the ARPE-19 retinal pigment epithelial cells we employed,
disruption of the retinal pigment epithelium was similarly
documented [52].
This investigation focuses on interactions between
DENV and the cells of the blood-retinal barrier. Another
aspect of the pathogenesis of dengue retinopathy is the inter-
action between DENV-infected retinal pigment epithelial
cells or retinal endothelial cells, as well as other retinal cell
populations, and the infiltrating leukocytes, which also may
be infected. Special immunological features of pigment epi-
thelial cells and endothelial cells influence the course of a ret-
inal inflammation. Retinal pigment epithelial cells produce a
range of immunomodulatory molecules that act to downreg-
ulate inflammatory activities of leukocyte populations [53].
On the other hand, retinal endothelial cells constitutively
express relatively high levels of cell adhesion molecules and
chemokines, and they have the capacity to produce a variety
of other molecules that may act to promote inflammation
[54]. Studies of leukocyte-retinal cell interactions should fur-
ther illuminate the mechanisms of dengue retinopathy.
An important question is the impact of an individual
viral phenotype on interactions with the host cell. Our pri-
mary goal in this work was to initiate an investigation into
the basic mechanisms of dengue retinopathy. Therefore, for
these experiments, we selected the Mon601 strain, which is
widely used in studies of DENV infection, being pathogenic
and one of the first established as a reliable molecular clone
[20]. The comparison of two dengue epidemics in Singapore,
in which different DENV serotypes predominated, yielded
different prevalences for dengue maculopathy, suggesting
viral phenotype may impact clinical manifestations [55].
Serotype and disease associations are not straightforward to
identify, however, since although one serotype may predom-
inate during an epidemic, the infecting serotypes are often
not defined, and in addition to serotype associations, there
also may be strain associations. A comprehensive investiga-
tion of the effect of viral phenotype in dengue retinopathy
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will need to consider not only serotypes 1 through 4, but also
multiple strains of each of the 4 serotypes.
In summary, we have demonstrated that human retinal
pigment epithelial cells and human retinal endothelial cells
are permissive to infection with DENV, and we have pro-
vided molecular correlations for common manifestations of
dengue retinopathy. Our work was conducted in vitro, using
an infectious, recombinant DENV-2 clone and characterized
human retinal cell lines, and key findings of our study were
replicated in primary human retinal cells, and with the
PUO-312 strain DENV-2, which was isolated from an
infected human. In vitro cell responses may not predict the
clinical disease in vivo in the human host. In vitro studies
with human retinal cells are helpful for understanding den-
gue maculopathy in particular, since primates are the only
mammals with a macula, and nonhuman primates develop
little or no clinical disease following infection with dengue
[56]. However, in vivo studies in mice are likely to provide
mechanistic insights relating to other retinal manifestations;
we have detected DENV RNA in eyes of AG129 IFN
receptor-deficient mice and C57BL/6 mice following sys-
temic and intracranial DENV-2 infection, respectively, sug-
gesting that both may provide experimental models of
dengue eye disease (unpublished data). Cell populations
inside the blood-retinal barrier, including retinal neurons,
Müller glial cells, astrocytes, microglial cells, and pericytes,
also may participate in the pathogenesis of dengue retinopa-
thy; microglia may be important for an anti-DENV immune
response, as has been demonstrated in experimental enceph-
alitis [57]. Potential roles of these cells could be explored in
both in vitro and in vivo studies. Recognizing the need for
additional research in this new field, the present work pro-
vides a solid basis for future studies on the basic mechanisms
of dengue retinopathy, which ultimately should allow the
development of more specific treatments for this vision-
threatening condition.
5. Conclusions
Retinopathy, or disease involving the retina, is the most seri-
ous eye complication for individuals who become infected
with DENV. Our research seeks to explain the features of
dengue retinopathy, as seen in patients, at the molecular
level. This work focuses on the interaction between DENV
and two human retinal cell populations that are implicated
in this disease through clinical observations: pathological
changes along the retinal blood vessels and abnormal accu-
mulation of extracellular fluid in the central macular region
of retina implicate retinal endothelial cells and retinal pig-
ment epithelial cells. We find that both retinal cell popula-
tions support the replication and release of DENV, and
mount antiviral molecular responses, with some differences
in the level of these activities between the cell types. We show
that molecules that bind leukocytes are increased in infected
retinal endothelial cells, providing a basis for retinal vascular
pathology. We also identify alterations in intercellular junc-
tions following infection of pigment epithelial cells, but not
endothelial cells, that would promote leakage of extracellular
fluid into the retina. Our findings provide clinicopathological
correlations in dengue retinopathy and begin to address the
possibility of developing biologically relevant treatments for
this condition.
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